Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
GE HealthCare Technologies Inc. incurred revolving credit of $3.0 billion with JPMorgan Chase Bank, N.A. at alternate base rate or an adjusted Term SOFR rate for a one-, three-, or six-mon maturing March 27, 2030.
- Instrument
- revolving credit
- Principal
- $3.0 billion
- Counterparty
- JPMorgan Chase Bank, N.A.
- Rate
- alternate base rate or an adjusted Term SOFR rate for a one-, three-, or six-mon
- Maturity
- March 27, 2030
- Event
- incurrence
Exact text from the filing
Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides for a senior unsecured revolving credit facility in an aggregate committed amount of $3.0 billion. The 2025 Credit Agreement and the 2025 364-Day Revolving Credit Agreement are each referred to herein as a “New Credit Agreement” and collectively as the “New Credit
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
GE HealthCare Technologies Inc. incurred revolving credit of $0.5 billion with JPMorgan Chase Bank, N.A. at alternate base rate or an adjusted Term SOFR rate for a one-, three-, or six-mon maturing March 26, 2026.
- Instrument
- revolving credit
- Principal
- $0.5 billion
- Counterparty
- JPMorgan Chase Bank, N.A.
- Rate
- alternate base rate or an adjusted Term SOFR rate for a one-, three-, or six-mon
- Maturity
- March 26, 2026
- Event
- incurrence
Exact text from the filing
Bank, N.A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $0.5 billion, and (ii) a Credit Agreement (the “2025 Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides
View on SEC.gov